IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4002
Positioning
Market Dominance
Manufacturing
Pharmaceutical Products
$16M
Chun-Hsien Tsai
Ainos, Inc. engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$AIMD Ainos, Inc. | 36 | 28 | 40 | 47 | - | - | -139.4% | -61.7% | 87.6% | -82683.7% | -88057.3% | - | 0.0% | 126.0x | $16M | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
Ainos, Inc. (AIMD) receives a "Avoid" rating with a composite score of 36.1/100. It ranks #4002 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Chun-Hsien Tsai
Chief Executive Officer
Labor Force
40
28
25
14
Audit Verdict: Lower quality and stability scores may indicate governance concerns.
No recent insider transactions available for AIMD
In-line with peers — no strong momentum signal
Fair valuation relative to peers
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Aggressive spending — empire-building risk, dilutive growth
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for AIMD.
View All RatingsHigh margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 28 | 7 | +21ALPHA |
| MOMENTUM | 47 | 32 | +15ALPHA |
| VALUATION | 40 | 19 | +21ALPHA |
| INVESTMENT | 25 | 13 | +12ALPHA |
| STABILITY | 14 | 3 | +11ALPHA |
| SHORT INT | 49 | 47 | +2NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC -22.3% vs WACC 6.8% (spread -29.1%)
GM 88% vs sector 43%, OM -82684% vs sector 1%
Capital turnover 0.00x, R&D intensity 4998.7%
Rev growth N/A, 10yr history
Interest coverage -15.8x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our quantitative model flags Ainos, Inc. with an Avoid rating, assigning a composite score of 36.1/100 and 1 out of 5 stars. Ranked #4002 of 7,333 stocks, AIMD falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
AIMD's quality score of 28/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -139.4% (sector avg: -2.5%), gross margins of 87.6% (sector avg: 42.5%), net margins of -88057.3% (sector avg: -0.2%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
With a value score of 40/100, AIMD appears somewhat expensive relative to its fundamentals. Key valuation metrics include a P/B ratio of 0.93x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.
Ainos, Inc.'s investment score of 25/100 suggests limited reinvestment activity. Key growth metrics include a return on assets of -61.7% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
AIMD is currently showing below-average momentum at 47/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth data is not currently available, while a beta of 1.64 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
Ainos, Inc. registers a low stability score of 14/100, indicating high volatility and potentially stressed financial conditions. Key stability metrics include a beta of 1.64 and a debt-to-equity ratio of 126.00x (sector avg: 0.2x). Stocks at this level carry elevated capital loss risk and may be unsuitable for conservative portfolios without careful risk management.
The short interest score of 49/100 for AIMD suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include high market sensitivity (beta: 1.64), elevated leverage (D/E: 126.00x), micro-cap liquidity risk. With a $16M market cap (micro-cap), Ainos, Inc. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Ainos, Inc. is a micro-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #4002 of 7,333 overall (45th percentile). Key comparisons include ROE of -139.4% trailing the -2.5% sector median and operating margins of -82683.7% below the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While AIMD currently exhibits a AVOID profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Stability (14) would have the largest impact on the composite score.
ROE 5521% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 106% ABOVE SECTOR MEDIAN (FAVORABLE)
Op. Margin 6409687% BELOW SECTOR MEDIAN
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate Ainos, Inc. (AIMD) as Avoid with a composite score of 36.1/100 at a current price of $1.58. The stock falls in the bottom quintile of our universe across key quantitative factors, and the multi-factor weakness suggests a high probability of continued underperformance.
The rating is primarily driven by strength in momentum (47th percentile) and value (40th percentile), which together account for the majority of the composite score. Offsetting weakness in stability (14th percentile) and investment (25th percentile) tempers our overall conviction. We assign a No Moat rating (33/100), Very High uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress; the path to profitability. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
Ainos, Inc. holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 36.1/100 places it at rank #4002 in our full 7,333-stock universe. At $16M in market capitalization, Ainos, Inc. is a small-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Momentum indicators (47th percentile) are neutral regarding the near-term price trend. Revenue growth data is unavailable, limiting our ability to confirm whether momentum is fundamentally supported.
The margin cascade tells an important story: gross margins of 88% (+45.1pp vs sector) narrow to operating margins of -82684% (-82685.0pp vs sector) and net margins of -88057.3%, yielding a gross-to-net conversion rate of -100545%. The significant margin erosion from gross to net suggests elevated operating expenses, high interest costs, or other structural drags that warrant monitoring.
At a current price of $1.58, Ainos, Inc. is trading near fair value based on current fundamentals. Our value factor score of 40/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at P/B of 0.9x, P/S of 83.5x. We evaluate these multiples in the context of both absolute levels and sector-relative positioning to form our valuation view.
Gross margins of 88% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
The Avoid rating (composite 36.1/100) reflects multi-factor weakness, and historically, stocks in this scoring range have underperformed the market by a meaningful margin.
Elevated leverage (126% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Thin net margins of -88057.3% provide limited cushion against cost pressures, competitive pricing, or macroeconomic headwinds — even small changes in costs could swing the company to a loss.
Below-average quality (28th percentile) raises durability concerns about the fundamental profile and increases the risk of negative earnings surprises.
We assign a Very High uncertainty rating to Ainos, Inc.. The stock exhibits multiple compounding risk factors: elevated market sensitivity (beta of 1.64), significant leverage (126% debt-to-equity), current negative profitability (net margin -88057.3%). The extreme uncertainty around future cash flows makes precise valuation difficult, and the range of outcomes is exceptionally wide. Only investors with high risk tolerance and extended time horizons should consider this name.
Specific risk factors that inform our assessment include: elevated market sensitivity (beta of 1.64); significant leverage (126% debt-to-equity); current negative profitability (net margin -88057.3%); below-average price stability (14th percentile). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 14th percentile and quality factor at the 28th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 88% provide a buffer against cost pressures. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile warrants caution and disciplined position management.
We rate Ainos, Inc.'s capital allocation as Poor. Key concerns include low returns on equity (-139.4%), negative profitability, weak asset returns (ROA -61.7%). Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — Ainos, Inc. significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, Ainos, Inc. receives a Avoid rating with a composite score of 36.1/100 (rank #4002 of 7,333). Our quantitative framework assigns a No Moat (33/100, trend: stable), Very High uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 31/100.
Our analysis does not support a constructive view on Ainos, Inc. at this time. The combination of limited competitive advantages, very high uncertainty, and poor capital allocation suggests unfavorable risk-reward at current levels. We recommend investors avoid new positions and existing holders consider reducing exposure.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We do not assign Ainos, Inc. a meaningful economic moat, scoring 33/100 on our composite assessment. The ROIC-WACC spread of -29.1% is the primary signal of economic value creation. Current fundamentals do not demonstrate the kind of durable competitive advantages — such as superior returns on invested capital, margin superiority, or reinvestment efficiency — that would protect the company from competitive erosion over the long term. The highest-scoring pillar, reinvestment efficiency, reached only 14/20.
The strongest moat sources are reinvestment efficiency (14/20) and margin superiority (7.8/20). Capital turnover 0.00x, R&D intensity 4998.7%. GM 88% vs sector 43%, OM -82684% vs sector 1%. These pillars form the core of Ainos, Inc.'s competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include economic value creation (2.9/20) and growth durability (3.5/20). ROIC -22.3% vs WACC 6.8% (spread -29.1%). Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect Ainos, Inc.'s moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 88% providing a solid profitability foundation. The margin cascade from 88% gross to -82684% operating to -88057.3% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality raises some durability concerns, with the quality factor at the 28th percentile.
The margin profile shows gross margins of 88%, operating margins of -82684%, net margins of -88057.3%. Return metrics include ROE of -139.4% and ROA of -61.7%. Relative to the Manufacturing sector, gross margins are 45.1 percentage points above the sector median of 43%, and ROE of -139.4% compares to a sector median of -2.5%.
The balance sheet reflects above-average leverage with D/E of 126%. The sector median D/E is 0%, putting Ainos, Inc. at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
High beta of 1.64 means amplified losses in market selloffs — in a broad market correction, this stock would likely decline more than the index.
Above 50MA
37.18%
Net New Highs
+51081
Ainos (NASDAQ: AIMD) has partnered with Mirle Automation Corporation to integrate its AI Nose SmellTech into Mirle's robotic platforms, expanding deployments into industrial environments like semiconductor fabs and for border security. This collaboration aims to add chemical sensing to robots, enhancing the detection of gas leaks and volatile organic compounds while accelerating real-world data collection to scale Ainos' Smell ID library. The move positions AI Nose as a scalable growth engine for robotics, complementing existing vision and audio systems with scent intelligence.
Ainos (NASDAQ:AIMD) has secured $2.1 million in multi-year semiconductor back-end orders for approximately 1,400 AI Nose units, expanding its SmellTech platform into industrial environments. The company's dual-engine architecture, combining physical sensing with intelligence-as-a-service through its subsidiary ScentAI, aims for recurring subscription revenues. Partnerships and robotics integration are set to accelerate continuous scent data generation and scale-up efforts in 2026.

Taiwan Carbon Nano Technology Corp., a ten percent owner of Ainos, Inc. (NASDAQ:AIMD), sold 46,000 shares of common stock for approximately $99,806. This transaction occurred on January 28, 2026, at a price below the current trading price, following significant volatility in AIMD's stock. Despite recent gains, InvestingPro analysis suggests AIMD may be overvalued due to high debt and weak financial health, while Ainos continues to expand its AI Nose technology through distribution agreements.

Ainos, Inc. (NASDAQ: AIMD)(NASDAQ: AIMDW) announced it will participate in a fireside chat with Water Tower Research on January 26, 2026, at 11:00 a.m. ET. The company will discuss its SmellTech platform strategy, partnership with Trusval Technology, progress in AI Nose technology, and strategic priorities for 2026. This event aims to provide investors with insights into Ainos' technology roadmap and commercialization strategy.
Ainos (NASDAQ:AIMD) has announced a distribution and deployment agreement with Trusval Technology to expand its "AI Nose" technology into semiconductor front-end manufacturing. The deal includes an initial commitment for 600 AI Nose units, aiming to integrate scent detection capabilities into high-precision wafer fabrication environments. This move aligns with Ainos' 2026 strategy to broaden its SmellTech platform upstream from current back-end processes and to digitize scent as a native AI data language.